Jennifer L. Blanchfield, Ph.D.
Affiliations: | 2010 | Microbiology and Immunology | East Carolina University, Greenville, NC, United States |
Area:
Immunology, Molecular BiologyGoogle:
"Jennifer Blanchfield"Parents
Sign in to add mentor| Mark D. Mannie | grad student | 2010 | East Carolina University | |
| (Antigen-specific tolerogenic vaccines inhibit autoimmune disease in a rodent model of multiple sclerosis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Thomas AM, Beskid NM, Blanchfield JL, et al. (2020) Localized Hydrogel Delivery of Dendritic Cellsfor Attenuation of Multiple Sclerosis in a Murine Model. Journal of Biomedical Materials Research. Part A |
| Mannie MD, Blanchfield JL, Islam SM, et al. (2012) Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis. Frontiers in Immunology. 3: 255 |
| Abbott DJ, Blanchfield JL, Martinson DA, et al. (2011) Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE). Bmc Immunology. 12: 72 |
| Blanchfield JL, Mannie MD. (2010) A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC. Journal of Leukocyte Biology. 87: 509-21 |
| Mannie MD, Abbott DJ, Blanchfield JL. (2009) Experimental autoimmune encephalomyelitis in Lewis rats: IFN-beta acts as a tolerogenic adjuvant for induction of neuroantigen-dependent tolerance. Journal of Immunology (Baltimore, Md. : 1950). 182: 5331-41 |